Bunostomum phlebotomum Cattle Hookworm: Percutaneous Larval Infection and Dermatitis

Introduction

Bunostomum phlebotomum is a hematophagous hookworm parasite of cattle, primarily affecting young animals in tropical and subtropical regions. The species belongs to the family Ancylostomatidae and is characterized by a large buccal capsule armed with cutting plates, which facilitates attachment to the intestinal mucosa and blood feeding [1]. Unlike many other gastrointestinal nematodes of ruminants, B. phlebotomum possesses a dual infection route: oral ingestion of third-stage larvae (L3) and percutaneous penetration of L3 through the skin [2, 3]. The percutaneous route is of particular clinical significance because it induces a localized inflammatory dermatitis at the site of larval entry, a condition often referred to as hookworm dermatitis or "bunostomosis-associated dermatopathy" [4]. This article provides a comprehensive, publication-grade review of the percutaneous larval infection mechanism, the resulting dermatitis, diagnostic approaches, and integrated control strategies for B. phlebotomum in cattle.

Etiology and Morphology

Bunostomum phlebotomum is a robust, reddish-gray nematode. Adult males measure approximately 10–17 mm in length, while females are larger at 19–26 mm [1]. The anterior end is curved dorsally, and the buccal capsule contains two pairs of subventral cutting plates and a dorsal tooth, structures essential for tissue attachment and blood feeding [2]. The eggs are thin-shelled, ellipsoidal, and contain a morula when freshly passed in feces; they measure approximately 90–110 µm by 40–50 µm [3]. The life cycle is direct, with eggs hatching in the environment to release first-stage larvae (L1), which develop through L2 and L3 stages under favorable conditions of moisture and temperature (optimal range 22–28°C) [4].

Life Cycle and Percutaneous Infection Pathway

The life cycle of B. phlebotomum involves both free-living and parasitic stages. Eggs are shed in the feces of infected cattle. Under optimal environmental conditions, L1 hatch within 24–48 hours and feed on bacteria in the fecal mass [1]. Development to the infective L3 stage occurs over 7–10 days [2]. The L3 are ensheathed and exhibit a characteristic "leaping" or "waving" behavior on pasture, which facilitates contact with the host [3].

Percutaneous infection occurs when L3 larvae contact the skin of grazing cattle, particularly on the lower limbs, ventral abdomen, and udder [4]. The larvae penetrate the epidermis using a combination of mechanical force and enzymatic secretion. The anterior end of the L3 bears a stylet-like structure, and the larvae secrete proteolytic enzymes, including metalloproteases and serine proteases, that degrade collagen and other extracellular matrix components in the dermis [5]. This enzymatic activity facilitates migration through the stratum corneum and into the deeper dermal layers.

Once through the skin, the larvae enter the subcutaneous vasculature or lymphatic vessels and are carried to the lungs via the venous circulation [1]. In the pulmonary capillaries, the larvae break into the alveoli, migrate up the bronchial tree to the trachea, and are then coughed up and swallowed [2]. After reaching the small intestine, the larvae molt to L4 and then to adults. The prepatent period is approximately 50–60 days [3].

Pathogenesis of Dermatitis

The dermatitis caused by B. phlebotomum is a direct consequence of the host's inflammatory response to larval invasion. The initial penetration of L3 triggers an immediate type I hypersensitivity reaction, mediated by IgE antibodies and mast cell degranulation, leading to vasodilation and edema [4]. Within 12–24 hours, a delayed-type hypersensitivity response develops, characterized by infiltration of neutrophils, eosinophils, and macrophages at the penetration sites [5].

Grossly, affected skin areas exhibit erythematous papules, serous exudation, and crust formation. In heavy infestations, the lesions may coalesce into plaques with alopecia and lichenification [1]. Pruritus is a prominent clinical sign, leading to self-trauma, secondary bacterial infections, and further exacerbation of the dermatitis [2]. Histopathological examination reveals focal epidermal necrosis, spongiosis, and a dense perivascular inflammatory infiltrate in the dermis [3]. Eosinophilic microabscesses may be present in the stratum corneum.

The severity of dermatitis is dose-dependent and correlates with the number of penetrating larvae [4]. Repeated exposure to B. phlebotomum can lead to chronic dermatitis with fibrosis and hyperkeratosis [5]. The condition is most commonly observed in calves and yearlings, as older animals often develop partial immunity that reduces larval penetration and skin inflammation [1].

Clinical Signs in Cattle

Clinical signs of B. phlebotomum infection can be divided into cutaneous and systemic manifestations. The cutaneous signs include:

• Erythematous papules and pustules on the lower limbs, ventral abdomen, and udder [2].
• Serous exudation and crusting, often with matted hair [3].
• Alopecia and lichenification in chronic cases [4].
• Intense pruritus, leading to rubbing and self-trauma [5].

Systemic signs are primarily due to the blood-feeding activity of adult worms in the small intestine. These include:

• Progressive anemia (normocytic, normochromic) due to blood loss [1].
• Hypoproteinemia, particularly hypoalbuminemia, resulting from protein-losing enteropathy [2].
• Weight loss, poor growth rates, and reduced feed conversion efficiency [3].
• Diarrhea, which may be mucoid or hemorrhagic in heavy infections [4].

In severe cases, calves may develop submandibular edema (bottle jaw) and become lethargic [5]. Mortality is uncommon but can occur in heavily parasitized, malnourished animals [1].

Diagnosis

Diagnosis of B. phlebotomum infection relies on a combination of clinical history, physical examination, fecal analysis, and, where available, molecular techniques.

Fecal Examination

Standard fecal flotation using saturated salt or sugar solutions (specific gravity 1.20–1.25) is used to detect Bunostomum eggs [2]. The eggs are morphologically similar to those of other strongylid nematodes, but they are slightly larger and have a more pronounced morula [3]. Quantitative fecal egg counts (FEC) using the McMaster technique are recommended to estimate the intensity of infection [4]. A FEC of greater than 200 eggs per gram (EPG) is generally considered indicative of a significant parasitic burden [5].

Larval Culture and Identification

To differentiate B. phlebotomum from other strongylid species, fecal cultures are performed to obtain L3 larvae. The larvae are identified based on morphological features, including the length of the tail sheath and the number of intestinal cells [1]. B. phlebotomum L3 have a characteristic long, filamentous tail sheath and 16 intestinal cells [2].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the internal transcribed spacer 2 (ITS-2) region of ribosomal DNA have been developed for specific detection of B. phlebotomum in fecal samples [3]. These assays offer high sensitivity and specificity, allowing for the detection of mixed infections and low-level infestations [4]. Quantitative PCR (qPCR) can also be used to estimate parasite burden [5].

Serology

Enzyme-linked immunosorbent assays (ELISAs) using recombinant antigens from B. phlebotomum have been explored for serological diagnosis [1]. These tests detect antibodies against larval or adult worm antigens and can be useful for herd-level surveillance [2]. However, cross-reactivity with other hookworm species may occur [3].

Differential Diagnosis

The dermatitis caused by B. phlebotomum must be differentiated from other causes of bovine skin disease, including:

• Dermatophilosis (Dermatophilus congolensis): Characterized by scabby, exudative lesions that are not typically pruritic [4].
• Ringworm (Trichophyton verrucosum): Circular, alopecic lesions with scaling, usually non-pruritic [5].
• Mange (e.g., Sarcoptes scabiei var. bovis): Intensely pruritic, with crusting and alopecia; skin scrapings reveal mites [1].
• Photosensitization: Lesions on non-pigmented skin, with no pruritus [2].
• Insect bite hypersensitivity: Seasonal occurrence, with lesions on the dorsum and flanks [3].

Treatment and Control

Anthelmintic Therapy

Treatment of B. phlebotomum infection relies on the use of broad-spectrum anthelmintics. The following classes are effective:

• Macrocyclic lactones (e.g., ivermectin, doramectin, eprinomectin): These drugs are highly effective against both adult worms and L4 larvae [4]. They also have some activity against L3 during tissue migration [5].
• Benzimidazoles (e.g., fenbendazole, albendazole): Effective against adult worms, but less potent against larval stages [1].
• Imidazothiazoles (e.g., levamisole): Effective against adult worms, but with a narrower safety margin [2].

Resistance to benzimidazoles has been reported in some populations of B. phlebotomum, necessitating the use of fecal egg count reduction tests (FECRT) to monitor efficacy [3].

Management of Dermatitis

Topical treatment of dermatitis involves cleansing the affected areas with mild antiseptic solutions (e.g., chlorhexidine) and applying anti-inflammatory creams containing corticosteroids to reduce pruritus [4]. Secondary bacterial infections should be treated with appropriate topical or systemic antibiotics based on culture and sensitivity results [5].

Pasture Management

Since B. phlebotomum larvae develop on pasture, grazing management is critical for control. Strategies include:

• Rotational grazing: Moving cattle to clean pastures every 3–4 weeks to break the life cycle [1].
• Resting pastures: Allowing pastures to remain ungrazed for 6–8 weeks during warm weather to reduce larval populations [2].
• Mixed grazing: Co-grazing with sheep or horses, which are not susceptible to B. phlebotomum, can reduce pasture contamination [3].
• Avoiding overstocking: High stocking densities increase fecal contamination and larval exposure [4].

Integrated Control

An integrated parasite management (IPM) approach combines anthelmintic treatment, pasture management, and monitoring. The following decision tree illustrates a typical IPM workflow for B. phlebotomum control.

flowchart TD
    A[Calves 3-6 months old] --> B["Fecal Egg Count (FEC")]
    B --> C{FEC > 200 EPG?}
    C -->|Yes| D[Administer macrocyclic lactone]
    C -->|No| E[Monitor monthly]
    D --> F[Perform FECRT 14 days post-treatment]
    F --> G{FECRT < 90% reduction?}
    G -->|Yes| H[Switch anthelmintic class]
    G -->|No| I[Continue with same class]
    H --> J[Re-test FECRT]
    I --> K[Implement pasture rotation]
    J --> K
    K --> L[Repeat FEC in 3 months]
    L --> M{Clinical signs present?}
    M -->|Yes| N[Examine for dermatitis]
    M -->|No| O[Continue monitoring]
    N --> P[Dermatitis confirmed?]
    P -->|Yes| Q[Topical treatment + anthelmintic]
    P -->|No| R[Re-evaluate diagnosis]
    Q --> S[Return to monitoring schedule]

Public Health and Zoonotic Considerations

Bunostomum phlebotomum is not considered a significant zoonotic pathogen. However, the larvae of some hookworm species, such as Ancylostoma caninum and Ancylostoma braziliense, can cause cutaneous larva migrans in humans [1]. While B. phlebotomum has not been definitively linked to human disease, the potential for percutaneous larval penetration in humans cannot be entirely excluded, particularly in individuals with prolonged contact with contaminated soil [2]. Standard hygiene practices, including wearing gloves and boots when handling soil or manure, are recommended for farm workers [3].

Conclusion

Bunostomum phlebotomum is a significant parasitic nematode of cattle, causing both intestinal disease and a distinctive percutaneous dermatitis. The dermatitis results from the host's inflammatory response to larval invasion and is characterized by pruritus, erythema, and exudation. Diagnosis relies on fecal examination, larval culture, and molecular methods. Control requires an integrated approach combining effective anthelmintic therapy, pasture management, and monitoring of drug efficacy. Understanding the percutaneous infection pathway is essential for developing targeted prevention strategies and mitigating the economic impact of this parasite on cattle production.

References

[1] Bowman, D.D. (2014). Georgis' Parasitology for Veterinarians. Elsevier.

[2] Taylor, M.A., Coop, R.L., & Wall, R.L. (2016). Veterinary Parasitology. Wiley Blackwell.

[3] Zajac, A.M., & Conboy, G.A. (2012). Veterinary Clinical Parasitology. Wiley Blackwell.

[4] Urquhart, G.M., Armour, J., Duncan, J.L., Dunn, A.M., & Jennings, F.W. (1996). Veterinary Parasitology. Blackwell Science.

[5] Hendrix, C.M., & Robinson, E. (2017). Diagnostic Parasitology for Veterinary Technicians. Elsevier. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.